Non-Squamous Non-Small Cell Lung Cancer Terminated Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Non-squamous Non-small Cell Lung Cancer

IndicationStatusPhase
DBCOND0036730 (Non-Squamous Non-Small Cell Lung Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00642824A Genetic Substudy Associated With the Avastin (Bevacizumab) Study MO19390 in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.Treatment
NCT01057212Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)Treatment